{"width":"100%","author_url":"https://blog.hatena.ne.jp/pseudomonas/","published":"2022-02-13 13:38:54","height":"190","author_name":"pseudomonas","provider_url":"https://hatena.blog","description":"\u89e3\u8aac ClinGen SVI Recommendation of in trans criterion (PM3)","type":"rich","url":"https://clinical-genetics.hatenadiary.com/entry/20220213/1644727134","categories":[],"title":"ClinGen SVI\u306b\u3088\u308bPM3\u57fa\u6e96\u306e\u63a8\u5968\u4e8b\u9805","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fclinical-genetics.hatenadiary.com%2Fentry%2F20220213%2F1644727134\" title=\"ClinGen SVI\u306b\u3088\u308bPM3\u57fa\u6e96\u306e\u63a8\u5968\u4e8b\u9805 - \u81e8\u5e8a\u30d0\u30a4\u30aa\u30a4\u30f3\u30d5\u30a9\u30de\u30c6\u30a3\u30b7\u30e3\u30f3\u306e\u30d6\u30ed\u30b0\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","version":"1.0","blog_title":"\u81e8\u5e8a\u30d0\u30a4\u30aa\u30a4\u30f3\u30d5\u30a9\u30de\u30c6\u30a3\u30b7\u30e3\u30f3\u306e\u30d6\u30ed\u30b0","image_url":null,"blog_url":"https://clinical-genetics.hatenadiary.com/","provider_name":"Hatena Blog"}